These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 35060407)

  • 41. Patterns of ambulatory medical care utilization and rheumatologist consultation predating the diagnosis of systemic lupus erythematosus: a national population-based study.
    Lai NS; Tsai TY; Koo M; Huang KY; Tung CH; Lu MC
    PLoS One; 2014; 9(7):e101485. PubMed ID: 24999630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Burden of lupus activity on health care resources utilization in Buenos Aires, Argentina.
    Alvarado RN; Alle G; Tobar-Jaramillo MA; Palomino LC; Cáceres AG; Rosa JE; Machnicki G; Zazzetti F; Soriano E; Scolnik M
    Lupus; 2023 Dec; 32(14):1656-1665. PubMed ID: 37955177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mortality and disease related comorbidities in systemic lupus erythematosus: Data from an Egyptian cohort.
    A Mohammed RH; Lotfy Fayed H; Ibrahim Emara N
    Lupus; 2022 Apr; 31(5):628-636. PubMed ID: 35306918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
    Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
    Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study.
    Cortés-Hernández J; Marras Fernández-Cid C; Andreu Sánchez JL; Calvo Alén J; García-Aparicio AM; Díez Álvarez E; Hidalgo Bermejo FJ; Coronell C; Perna A; Ordi Ros J
    Reumatol Clin (Engl Ed); 2023; 19(6):312-318. PubMed ID: 37286267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims.
    Garris C; Shah M; Farrelly E
    Cost Eff Resour Alloc; 2015; 13():9. PubMed ID: 26019689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort.
    Cann MP; Sage AM; McKinnon E; Lee SJ; Tunbridge D; Larkins NG; Murray KJ
    Lupus; 2022 Feb; 31(2):246-255. PubMed ID: 35037500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
    Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus.
    Tarazi M; Gaffney RG; Kushner CJ; Chakka S; Werth VP
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1404-1409. PubMed ID: 31058462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.
    Altabás-González I; Rua-Figueroa I; Mouriño C; Roberts K; Jimenez N; Martinez-Barrio J; Galindo M; Calvo Alén J; Pérez VDC; Uriarte Itzazelaia E; Tomero E; Freire-González M; Martínez Taboada V; Salgado E; Vela P; Fernandez-Nebro A; Olivé A; Narváez J; Menor-Almagro R; Soler GS; Hernández-Beriain JÁ; Manero J; Aurrecoechea E; Ibarguengoitia-Barrena O; Montilla C; Bonilla G; Torrente-Segarra V; Cacheda AP; García-Villanueva MJ; Moriano-Morales C; Manteca CF; Lozano-Rivas N; Bohórquez C; Pego-Reigosa JM
    Lupus Sci Med; 2024 Aug; 11(2):. PubMed ID: 39097409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement activation products vs standard ANA testing: Treatment outcomes, diagnosis, and economic impact (CAPSTONE) in systemic lupus erythematosus.
    O'Malley T; Xie F; Su Y; Clinton C; Zack DJ; Haechung C; Grabner M; Curtis JR
    J Manag Care Spec Pharm; 2022 Sep; 28(9):1021-1032. PubMed ID: 35775579
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment patterns in paediatric and adult patients with SLE: a retrospective claims database study in the USA.
    Brunner HI; Vadhariya A; Dickson C; Crandall W; Kar-Chan Choong C; Birt JA; Ruperto N; Ramanan AV
    Lupus Sci Med; 2023 Jul; 10(2):. PubMed ID: 37429670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data.
    Moores KG; Sathe NA
    Vaccine; 2013 Dec; 31 Suppl 10():K62-73. PubMed ID: 24331075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
    Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
    J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and financial burden of active lupus in Greece: a nationwide study.
    Bertsias G; Karampli E; Sidiropoulos P; Gergianaki I; Drosos A; Sakkas L; Garyfallos A; Tzioufas A; Vassilopoulos D; Tsalapaki C; Sfikakis P; Panopoulos S; Athanasakis K; Perna A; Psomali D; Kyriopoulos J; Boumpas D
    Lupus; 2016 Oct; 25(12):1385-94. PubMed ID: 27055520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The economic burden of systemic lupus erythematosus in Mexico.
    Elsisi GH; Andrade-Ortega L; Portela M; Ramírez GM
    J Med Econ; 2024; 27(sup1):12-22. PubMed ID: 38468477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS).
    Dhital R; Pokharel A; Karageorgiou I; Poudel DR; Guma M; Kalunian K
    Lupus; 2023 Dec; 32(14):1646-1655. PubMed ID: 37961765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Determinant Factors of Morbidity in Patients with Systemic Lupus Erythematosus].
    Jacinto M; Silva E; Riso N; Moraes-Fontes MF
    Acta Med Port; 2017 May; 30(5):368-372. PubMed ID: 28865500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a claims-based flare algorithm for systemic lupus erythematosus.
    Goetz I; Choong C; Winnie J; Nelson DR; Birt J; Noxon V; Varker H; Zimmerman N; Tkacz J
    Curr Med Res Opin; 2022 Sep; 38(9):1641-1649. PubMed ID: 35866412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.